These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 471426)

  • 1. Chemotherapeutic agents and estradiol receptor binding capacity.
    Görlich M; Heise E; Számel I; Kerpel-Fronius S
    Oncology; 1979; 36(4):149-55. PubMed ID: 471426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of intracellular equilibria and the effect of antiestrogens on estrogen-receptor dissociation kinetics from perfused cultures of human breast cancer cells.
    Strobl JS; Monaco ME; Lippman ME
    Endocrinology; 1980 Aug; 107(2):450-60. PubMed ID: 7389663
    [No Abstract]   [Full Text] [Related]  

  • 3. Specific binding and biological response of antiestrogens in the fetal uterus of the guinea pig.
    Gulino A; Pasqualini JR
    Cancer Res; 1980 Oct; 40(10):3821-6. PubMed ID: 7438065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen binding sites in the nucleus of normal and malignant human tissue: characteristics of the multiple nuclear binding sites.
    Syne JS; Markaverich BM; Clark JH; Panko WB
    Cancer Res; 1982 Nov; 42(11):4449-54. PubMed ID: 7127287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dephosphorylation of oestradiol nuclear receptor in vitro. A hypothesis on the mechanism of action of non-steroidal anti-oestrogens.
    Auricchio F; Migliaccio A; Castoria G
    Biochem J; 1981 Sep; 198(3):699-702. PubMed ID: 6275856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
    Lippman M; Bolan G; Huff K
    Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estradiol dependent decrease of binding inhibition by anti-estrogens (a possible test of receptor activation).
    Rochefort H; Capony F
    Biochem Biophys Res Commun; 1977 Mar; 75(2):277-85. PubMed ID: 557979
    [No Abstract]   [Full Text] [Related]  

  • 8. The binding of tamoxifen to oestrogen receptor proteins under equilibrium and non-equilibrium conditions.
    Nicholson RI; Syne JS; Daniel CP; Griffiths K
    Eur J Cancer (1965); 1979 Mar; 15(3):317-29. PubMed ID: 446514
    [No Abstract]   [Full Text] [Related]  

  • 9. Contribution to the mechanism of Stilbostat action.
    Görlich M; Heise E
    Neoplasma; 1976; 23(4):363-9. PubMed ID: 1004653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of nuclear estrogen-binding sites in the rat uterus: a simple method for the quantitation of type I and type II sites by [3H]estradiol exchange.
    Markaverich BM; Williams M; Upchurch S; Clark JH
    Endocrinology; 1981 Jul; 109(1):62-9. PubMed ID: 7238414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of delta-5-androstene-3beta, 17beta-diol with estradiol and dihydrotestosterone receptors in human myometrial and mammary cancer tissue.
    Poortman J; Prenen JA; Schwarz F; Thijssen JH
    J Clin Endocrinol Metab; 1975 Mar; 40(3):373-9. PubMed ID: 163841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chemotherapeutic agents on the formation of estrogen-receptor complex in human breast tumor cytosol.
    Müller RE; Sheard BE; Traish A; Wotiz HH
    Cancer Res; 1980 Aug; 40(8 Pt 1):2941-2. PubMed ID: 7388845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nafoxidine on the luteinizing hormone surge: temporal distribution of estrogen receptors and induction of cytoplasmic progestin receptors in the hypothalamus-preoptic area, pituitary, and uterus of the immature rat.
    Attardi B; Palumbo LA
    Endocrinology; 1981 Nov; 109(5):1365-74. PubMed ID: 7297482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple modification of the estrogen receptor exchange assay: validation in nuclei from the rat uterus and a mouse mammary tumor.
    Schoenberg DR; Clark JH
    Endocrinology; 1980 Jan; 106(1):56-60. PubMed ID: 7349972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-steroidal antioestrogens--receptor binding and biological response in rat uterus, rat mammary carcinoma and human breast cancer cells.
    Wakeling AE; Valcaccia B; Newboult E; Green LR
    J Steroid Biochem; 1984 Jan; 20(1):111-20. PubMed ID: 6538611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid hormone receptors in mammary carcinoma: the effect of tamoxifen.
    Koenders AJ; Beex LV; Geurts-Moespot J; Benraad TJ
    Eur J Cancer (1965); 1980; Suppl 1():63-6. PubMed ID: 7318871
    [No Abstract]   [Full Text] [Related]  

  • 17. An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues.
    Markaverich BM; Roberts RR; Alejandro MA; Clark JH
    Cancer Res; 1984 Apr; 44(4):1515-9. PubMed ID: 6704964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of estradiol receptors in rat uterine cytosol by sensitivity to tamoxifen.
    Fishman JH; Fishman J
    Biochem Biophys Res Commun; 1979 Mar; 87(2):550-8. PubMed ID: 444239
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiestrogenic and antitumor effects of droloxifene in experimental breast carcinoma.
    Kawamura I; Mizota T; Mukumoto S; Manda T; Masuda K; Nakamura T; Kubota H; Matsumoto S; Nishigaki F; Shimomura K
    Arzneimittelforschung; 1989 Aug; 39(8):889-93. PubMed ID: 2818677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different stability during incubation in vitro of the induced-protein (IP) response elicited in the rat uterus by treatment in vivo with oestradiol-17 beta or Nafoxidine [proceedings].
    Mairesse N; Galand P
    Arch Int Physiol Biochim; 1977 Dec; 85(5):1003-4. PubMed ID: 79342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.